Wasatch Advisors Inc Castle Biosciences Inc Transaction History
Wasatch Advisors Inc
- $18.5 Billion
- Q2 2024
A detailed history of Wasatch Advisors Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Wasatch Advisors Inc holds 2,327,936 shares of CSTL stock, worth $78.6 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
2,327,936
Previous 2,551,088
8.75%
Holding current value
$78.6 Million
Previous $56.5 Million
10.31%
% of portfolio
0.27%
Previous 0.3%
Shares
20 transactions
Others Institutions Holding CSTL
# of Institutions
173Shares Held
25.5MCall Options Held
511KPut Options Held
130K-
Black Rock Inc. New York, NY3.04MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$53.3 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.5MShares$50.6 Million0.02% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.22MShares$41.1 Million0.44% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.21MShares$40.9 Million2.33% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $888M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...